Sarah Boyce

Insider Reports History

Entity
Individual
Location
C/O Ionis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad, CA
Signature
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sarah Boyce:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avidity Biosciences, Inc. President and CEO, Director Common Stock 265K $8.66M $32.66 Dec 18, 2024 Direct
OmniAb, Inc. Director Common Stock 68.4K $302K $4.42 Jun 18, 2024 Direct
LIGAND PHARMACEUTICALS INC Former Director Common Stock 2.89K $209K $72.31 Nov 1, 2022 Direct
Berkeley Lights, Inc. Director Common Stock 1.4K $770 $0.55 May 14, 2021 Direct
Avidity Biosciences, Inc. President and CEO, Director Stock Option (Right to Buy) 461K Aug 6, 2024 Direct
OmniAb, Inc. Director Stock Option (right to buy) 40K Jun 18, 2024 Direct
Contineum Therapeutics, Inc. Director Stock Option (right to buy) 29.5K Jun 24, 2024 Direct
OmniAb, Inc. Director Restricted Stock Units 20K Jun 18, 2024 Direct
Berkeley Lights, Inc. Director Stock Option (Right to Buy) 4.9K May 14, 2021 Direct
LIGAND PHARMACEUTICALS INC Former Director Employee Stock Option (right to buy) 0 Nov 1, 2022 Direct

Insider Reports Filed by Sarah Boyce

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNA Avidity Biosciences, Inc. Dec 18, 2024 1 -$1.04M 4 Dec 19, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Sep 19, 2024 3 -$1.45M 4 Sep 23, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Aug 6, 2024 3 -$1.18M 4 Aug 7, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Jul 9, 2024 3 -$1.08M 4 Jul 11, 2024 President and CEO, Director
CTNM Contineum Therapeutics, Inc. Jun 24, 2024 1 $0 4 Jun 24, 2024 Director
CTNM Contineum Therapeutics, Inc. Jun 24, 2024 0 $0 3 Jun 24, 2024 Director
OABI OmniAb, Inc. Jun 18, 2024 4 $0 4 Jun 21, 2024 Director
RNA Avidity Biosciences, Inc. Jun 17, 2024 3 -$1.26M 4 Jun 20, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Jun 12, 2024 9 -$11.2M 4 Jun 14, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Jun 4, 2024 3 -$733K 4 Jun 5, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. May 7, 2024 3 -$680K 4 May 7, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Apr 2, 2024 3 -$700K 4 Apr 3, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Mar 8, 2024 6 -$2.29M 4 Mar 12, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Mar 1, 2024 3 -$1.59M 4 Mar 5, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Jan 20, 2024 3 -$51.6K 4 Jan 23, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Sep 11, 2023 1 $0 4 Sep 12, 2023 President and CEO, Director
OABI OmniAb, Inc. Jun 23, 2023 2 $0 4 Jun 27, 2023 Director
RNA Avidity Biosciences, Inc. Feb 1, 2023 9 -$1.16M 4 Feb 3, 2023 President and CEO, Director
OABI OmniAb, Inc. Jan 30, 2023 2 $0 4 Feb 1, 2023 Director
RNA Avidity Biosciences, Inc. Jan 20, 2023 2 $0 4 Jan 24, 2023 President and CEO, Director
OABI OmniAb, Inc. Nov 9, 2022 2 $101K 4 Nov 14, 2022 Director
OABI OmniAb, Inc. Nov 1, 2022 1 $0 4/A Apr 23, 2024 Director
OABI OmniAb, Inc. Nov 1, 2022 5 $0 4 Nov 3, 2022 Director
LGND LIGAND PHARMACEUTICALS INC Nov 1, 2022 2 $0 4 Nov 3, 2022 Former Director
OABI OmniAb, Inc. Nov 1, 2022 0 $0 3 Nov 3, 2022 Director
RNA Avidity Biosciences, Inc. Aug 24, 2022 6 -$1.08M 4 Aug 26, 2022 President and CEO, Director
RNA Avidity Biosciences, Inc. Aug 15, 2022 3 -$2.12K 4 Aug 17, 2022 President and CEO, Director
LGND LIGAND PHARMACEUTICALS INC Jun 10, 2022 2 $0 4 Jun 13, 2022 Director
RNA Avidity Biosciences, Inc. Jan 21, 2022 1 $0 4 Mar 15, 2022 President and CEO, Director
LGND LIGAND PHARMACEUTICALS INC Jun 4, 2021 2 $0 4 Jun 7, 2021 Director
CELL Berkeley Lights, Inc. May 14, 2021 2 $0 4 May 18, 2021 Director